SCHEMBL23013174

SCHEMBL23013174

O=C(O)NCC1CCN(Cc2cccnc2)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1I Q9P0X4 1/20 0.69
SIGMAR1 Q99720 1/20 0.59
HTR4 Q13639 1/20 0.57
CHRM4 P08173 1/20 0.56
KDM4E B2RXH2 2/20 0.55
CXCR4 P61073 1/20 0.55
HDAC3 O15379 3/20 0.54
HDAC4 P56524 3/20 0.54
HDAC1 Q13547 3/20 0.54
HDAC7 Q8WUI4 3/20 0.54
HDAC2 Q92769 3/20 0.54
HDAC10 Q969S8 3/20 0.54
HDAC11 Q96DB2 3/20 0.54
HDAC8 Q9BY41 3/20 0.54
HDAC6 Q9UBN7 3/20 0.54
HDAC9 Q9UKV0 3/20 0.54
HDAC5 Q9UQL6 3/20 0.54
ACHE P22303 1/20 0.54
GSK3B P49841 1/20 0.54
CHRNB2 P17787 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23012935 0.84 SIGMAR1 (0.56) CACNA1ISIGMAR1KDM4ECXCR4HDAC3
SCHEMBL23013177 0.83 CACNA1I (0.61) CACNA1ISIGMAR1HTR4CHRM4KDM4E
SCHEMBL29508424 0.83 CACNA1I (0.61) CACNA1ISIGMAR1HTR4CHRM4KDM4E
SCHEMBL163098 0.82 SIGMAR1 (0.68) CACNA1ISIGMAR1CXCR4HDAC3HDAC4
SCHEMBL8146918 0.80 CHRM4 (0.63) CACNA1ISIGMAR1CHRM4ACHE
SCHEMBL18865857 0.80 HRH3 (0.52) CACNA1ICHRNB2CHRNA4
SCHEMBL5773896 0.80 VNN1 (0.58) CACNA1ISIGMAR1HTR4CHRM4KDM4E
SCHEMBL2868175 0.79 SIGMAR1 (0.58) CACNA1ISIGMAR1HTR4CHRM4KDM4E
SCHEMBL29960939 0.78 CACNA1I (0.66) CACNA1IHTR4CXCR4HDAC3HDAC4
SCHEMBL3942388 0.78 ACHE (0.67) CXCR4HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4017849-A1 ENZYME INHIBITORS Kalvista Pharmaceuticals Limited (GB) 2022-06-29 EP disclosed
WO-2021032934-A1 ENZYME INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-25 WO disclosed